Titel: 7th EMBL/EMBO Joint Conference 2006: Genes, brain/mind and behaviour

Termin: 3.11.2006, 8:00 Uhr, bis 4.11.2006, 18:45 Uhr

Veranstaltungsort:
European Molecular Biology Laboratory (EMBL)
Meyerhofstraße 1
69117 Heidelberg

Referenten: Alison Abbott (Nature, Germany) *** Turhan Canli (Stony Brook University, USA) *** Jean-Pierre Changeux (Collège de France, France) *** Raymond G. DeVries (University of Minnesota, USA) *** Barry Dickson (IMP, Austria) *** Thomas Dierks (University Hospital for Clinical Psychiatry, Switzerland) *** John Dupre (University of Exeter, UK) *** Martha J. Farah (University of Pennsylvania, USA) *** Cornelius Gross (EMBL Monterotondo, Italy) *** Jeffrey C. Hall (Brandeis University, USA) *** Ulrike Heberlein (UCSF, USA) *** Judy Illes (Stanford University, USA) *** Michael Kosfeld (University of Zürich, Switzerland) *** Klaus-Peter Lesch (University of Würzburg, Germany) *** Nikos Logothetis (MPI for Biological Cybernetics, Germany) *** Isabelle Mansuy (University of Zürich/ETHZ, Switzerland) *** Thomas Metzinger (Johannes Gutenberg-Universität, Germany) *** Hannah Monyer (University of Heidelberg, Germany) *** Jörg Naumann (Deutsches Hygiene-Museum, Germany) *** Erik Parens (The Hastings Centre, USA) *** Nikolas Rose (BIOS London School of Economics, UK) *** Steven P. R. Rose (Open University, UK) *** Adina Roskies (Dartmouth College, USA) *** Pierre Roubertoux (CNRS, France) *** Rava A. da Silveira (École Normale Supérieure, France) *** Wolf Singer (Max-Planck-Insititut für Hirnforschung, Germany) *** Jackie Leach Scully (Institut für Geschichte und Epistemologie der Medizin, Switzerland) *** Ilina Singh (BIOS London School of Economics, UK) *** Petra Störig (University of Düsseldorf, Germany) *** Lars E. Sundstrom (CSO of Capsant Neurotechnologies, Southampton, UK) *** Paul Root Wolpe (University of Pennsylvania, USA)

Weitere Informationen:
http://www.embl.org/aboutus/sciencesociety/conferences/2006/scope06.ht ...

Kurzbeschreibung: Research in the life sciences is revealing how genes are differentially expressed in the brain and how types of behavior reflect the functioning of different neural networks. Scientists are also exploring the relationship between the neurophysiology of the brain and the nature of consciousness.

Science and technology always work in tandem. Neurotechnology refers to the set of tools that have been developed to analyze and influence the human nervous system, especially the brain. We would like to assess the uses that are – or could in the future be - made of new neurological knowledge and technologies. What are the consequences when biochemical solutions to behavioral problems such as depression, addiction, or eating disorders take precedence over attempts to repair the social environment, or defective inter-personal relations? How do we avert the risk of psychopharmacology being abused for neurochemical enhancement?

While new knowledge coming out of the neurosciences has an enormous potential for beneficial applications in diverse fields, treating or manipulating the mind will also have important social, legal and bioethical implications. These are some of the main issues that will be the focus of the next inter-disciplinary EMBL/EMBO Science and Society conference in 2006 in Heidelberg, Germany.

Kontakt: Mr. Halldór Stefánsson
European Molecular Biology Laboratory (EMBL)
Meyerhofstraße 1
69117 Heidelberg
Tel.: +49 - (0)6221 - 3 87 84 93
Fax: +49 - (0)6221 - 3 87 85 25
halldor.stefansson@embl.de
http://www.embl.org/

Veranstalter: European Molecular Biology Laboratory (EMBL)

Schlagworte: Eugenik/Enhancement, Hirnforschung, Pharmazeutik